WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
There have been a variety of estimates of the benefits and harms of mammographic screening for breast cancer. A study aimed to assess the effect of screening for breast cancer on mortality and morbidity.
The researchers found that, while screening was likely to reduce breast cancer mortality, screening also led to a 30 percent rate of overdiagnosis and overtreatment -- which meant that all in all it actually increased the absolute risk by 0.5 percent.
According to the study, as reported by Green Med Info:
“This means that for every 2000 women invited for screening throughout 10 years, one will have her life prolonged and 10 healthy women, who would not have been diagnosed if there had not been screening, will be treated unnecessarily.”